Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome
JP Després, I Lemieux, A Pascot… - … , and vascular biology, 2003 - Am Heart Assoc
Recent data from Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial
(VA-HIT) have recently reported that pharmacological treatment with a fibrate (gemfibrozil) …
(VA-HIT) have recently reported that pharmacological treatment with a fibrate (gemfibrozil) …
[引用][C] Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome
JP Després, I Lemieux, A Pascot… - Arteriosclerosis …, 2003 - pubmed.ncbi.nlm.nih.gov
Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the
atherogenic dyslipidemia of the metabolic syndrome Gemfibrozil reduces plasma C-reactive …
atherogenic dyslipidemia of the metabolic syndrome Gemfibrozil reduces plasma C-reactive …
[引用][C] Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.
JP Després, I Lemieux, A Pascot… - … and Vascular Biology, 2003 - europepmc.org
Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the
atherogenic dyslipidemia of the metabolic syndrome. - Abstract - Europe PMC Sign in | Create …
atherogenic dyslipidemia of the metabolic syndrome. - Abstract - Europe PMC Sign in | Create …